"Finerenone cuts albuminuria in diabetic nephropathy"

"Adding the mineralocorticoid receptor antagonist finerenone to standard renin-angiotensin system (RAS) blockade decreased albuminuria and improved the urinary albumin/creatinine ratio in an industry-sponsored phase IIB clinical trial of diabetic nephropathy, according to a report published online Sept. 1 in JAMA."

Click here to read the full article

Source- http://www.clinicalendocrinologynews.com/specialty-focus/diabetes/single-article-page/finerenone-cuts-albuminuria-in-diabetic-nephropathy/7a2fbd960fb9cf3f5fd7b3237b09bd4d.html

#news #Type2diabetes #hottopics #nephropathy

Must Read